220 related articles for article (PubMed ID: 10567896)
21. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
[TBL] [Abstract][Full Text] [Related]
22. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
[TBL] [Abstract][Full Text] [Related]
24. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
Lindmark G
Br J Cancer; 1996 Nov; 74(9):1413-8. PubMed ID: 8912537
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
26. Cell proliferation-related markers in colorectal liver metastases: correlation with patient prognosis.
Costa A; Doci R; Mochen C; Bignami P; Faranda A; Gennari L; Silvestrini R
J Clin Oncol; 1997 May; 15(5):2008-14. PubMed ID: 9164212
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas.
Sun XF; Carstensen JM; Zhang H; Arbman G; Nordenskjöld B
Eur J Cancer; 1996 Oct; 32A(11):1963-7. PubMed ID: 8943682
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
Sinicrope FA; Hart J; Michelassi F; Lee JJ
Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
[TBL] [Abstract][Full Text] [Related]
29. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
32. Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study.
Tribukait B; Hammarberg C; Rubio C
Acta Pathol Microbiol Immunol Scand A; 1983 Mar; 91(2):89-95. PubMed ID: 6846020
[TBL] [Abstract][Full Text] [Related]
33. [Significance of apoptosis status and apoptosis-associated antigen expression in human colorectal adenocarcinoma sequence].
Li L; Yan L; Wei Y; Liu Z; Wang Z; Lei S; Huang G
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):185-7, 191. PubMed ID: 12212055
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nilsson E; Sjödahl R; Nordenskjöld B
Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):443-8. PubMed ID: 8291217
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma.
Zhao DP; Ding XW; Peng JP; Zheng YX; Zhang SZ
J Zhejiang Univ Sci B; 2005 Dec; 6(12):1163-9. PubMed ID: 16358373
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Zhang H; Stål O; Wingren S; Hatschek T; Nordenskjöld B
Lancet; 1992 Dec; 340(8832):1369-73. PubMed ID: 1360088
[TBL] [Abstract][Full Text] [Related]
38. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.
Allegra CJ; Paik S; Colangelo LH; Parr AL; Kirsch I; Kim G; Klein P; Johnston PG; Wolmark N; Wieand HS
J Clin Oncol; 2003 Jan; 21(2):241-50. PubMed ID: 12525515
[TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
